PRISM Stock IndexesCurrent Value% Change (Daily)% Change (Inception)Most ActiveTop % GainersTop % Losers
Biotech$41.70-2.1%-58.3%INO 3,136GOVX 10.117%CAPR -13.158%
Cannabis$78.30-3%-21.7%CGC 58,744HEXO 2.453%CLVR -9.565%
EV$45.10-3.5%-54.9%NKLA 94,711FSR 3.115%NKLA -10.191%
Healthcare$80.20-1.8%-19.8%NUTX 1,984LUCD 5.983%UPH -18.35%
MedDevices$98.10-1.3%-1.9%INMD 1,371ELMD 5.775%SIEN -7.914%
Pharmaceuticals$49.90-3.3%-50.1%PIRS 3,174OCUP 8.657%SYRS -18.734%
New Energy$372.40-5.2%272.4%RUN 9,324PEGY 5.203%VENG -20.368%
NextGen Tech$70.60-2.5%-29.4%SOUN 15,480BTCM 10.909%VRAR -15.217%
Oil & Gas$173.70-4.8%73.7%AR 4,739IMPP 3.798%ALPS -20.123%
Public Health$52.40-1.8%-47.6%ESPR 3,492PMCB 7.143%SNPX -9.091%
Zombie$213.40-2.1%113.4%RIVN 47,367PTON 6.733%BW -14.489%
Latest News

Prism View

Birkenstock Targets $10 Billion Mark for Wall Street Debut

The renowned German shoe brand, Birkenstock, backed by L Catterton, a private-equity heavyweight, is setting its sights on an approximate valuation of $10 billion as it preps for its U.S. initial public offering (IPO). According to a recent disclosure to…

Celebrating National Coffee Day: Brewing Investment Opportunities in the Coffee Market

Ah, coffee! As we celebrate National Coffee Day, whether you prefer a classic black, frothy cappuccino, trendy cold brew, or the basic pumpkin spice latte (it’s that time of year, Brittany!), there is no denying the allure of a perfectly…

SKYX to Significantly Expand Market Penetration with QUOIZEL Collaboration

Disruptive platform technology company, SKYX (Nasdaq: SKYX) will significantly increase its market penetration through a new collaboration with QUOIZEL, a U.S. leading lighting supplier and manufacturer. Rani Kohen, Founder and Executive Chairman of SKYX Platforms, said, “We are excited to…

Hollywood’s Turning Point: Navigating the Post-Strike Era and the Gaming Industry’s Rising Influence

The end of the writers strike signals a positive momentum shift in the Hollywood production landscape.…

Top Gainer and Losers from the Prism Market View Index.

$BBAI was the leader and $DMK was the largest detractor.

25 Year of Google: The Stock’s Performance Over the Years

Google (GOOG), now a subsidiary of Alphabet Inc., has been a prominent player in the tech…

Amgen Targets a Share of the Booming Obesity Market

With rising predictions for the obesity drug sector, Eli Lilly (LLY) and Novo Nordisk (NVO) have…

Feature Story

Happy Birthday to the Libras: Balancing Portfolios with These Stock Plays in A Horoscope

Saturday the 23rd made it official that it is now Libra Season, and we all have a Libra we know who comes to mind once that zodiac gets mentioned. Now, we aren’t big on “tooting horns” here, we usually are the ones who laugh, when people fall. However, we must say, Libras are some of the slickest in the zodiac. You can’t not like them, but will they ever make a decision to save their lives? (more…)

Bio View

Next-Gen Bipolar Disorder Treatment Progressing, Says Alzamend

Clinical stage biopharmaceutical company, Alzamend Neuro (Nasdaq: ALZN), has received a “Study May Proceed” letter from the FDA for a Phase IIA clinical study of AL001 for Bipolar Disorder (BD) type 1. Alzamend previously completed a Phase IIA study of…

BioStem Technologies Takes on Diabetic Foot Ulcers with Innovative Wound Care Product

BioStem Technologies (OTC: BSEM) has received Investigational Review Board (IRB) approval for a clinical studythat will investigate the utilization and effects of its VendajeⓇ wound care product in diabetic foot ulcers. Jason Matuszewski, Chief Executive Officer of BioStem, said, “We…

Bionomics Reports Positive Topline Data in PTSD Study, Shares Soar 249%

Bionomics Limited’s (Nasdaq: BNOX) Phase 2b study evaluating BNC210 in post-traumatic stress disorder (PTSD) has garnered positive topline results, sending the company’s share price soaring by 249% in intraday trading on Thursday. PTSD affects around 5% of all Americans and…

Clene Study Demonstrates Prolonged Life for ALS Patients

Clene (Nasdaq: CLNN) has shared long-term follow-up data for patients treated with CNM-Au8 30mg for up…

GeoVax Enhances Manufacturing Capabilities with Landmark Commercial License Agreement

Vaccines and immunotherapies company, GeoVax Labs, Inc., (Nasdaq: GOVX) will enhance its manufacturing capabilities following the…

Lexaria to Evaluate Impact of DehydraTECH™ on GLP-1 drugs used in Ozempic®, Wegovy® and Rybelsus®

Lexaria Bioscience Corp. (Nasdaq:LEXX) will expand its established diabetes study program, launching new human and animal…

Soleno Shares Skyrocket 500% as New Drug Controls Hunger in Obesity-Causing Rare Disease

Soleno Therapeutics (Nasdaq: SLNO) shares skyrocketed more than 500% after the company announced positive topline results…

Traders Lens

Sphere Entertainment Co.

$SPHR is leading the NYSE. Over the weekend they opened their new venue in Las Vegas with a performance from U2

Prism Daily

Top Gainers and Losers from the Prism Market View Index.

  $BTCM was the biggest winner of the entire group and $RIDEQ was the largest detractor. [Read More]

Sam Bankman-Fried, the mastermind behind the crypto giant FTX, faces a reckoning.

Sam Bankman-Fried, founder of the crypto firm FTX, leaving federal court in Manhattan in February. He is going on trial on charges of fraud and money laundering.Hiroko Masuike/The New York Times In this high-stakes courtroom drama, Sam Bankman-Fried, the mastermind behind the crypto giant FTX, faces a reckoning. Amidst fraud allegations, he steps into the… [Read More]

Market Update: Bond Yields on the Rise

Headlines: Bond Movement: 10-year Treasury yields increase to 4.64% amid anticipation for insights from Federal Reserve Chief Jerome Powell on rate direction. Equity Fluctuations: The S&P 500 shows downward trend post Tesla’s (TSLA) Q3 delivery and production shortfalls, causing its stock to drop by 1.8%. Government Actions: A recent agreement to avert a U.S. government… [Read More]